Primary breast cancer often displays only moderately increased glucose metabolism
resulting in a low sensitivity of positron emission tomography (PET) using [F-18] …

Purpose The aim of the study was to assess the role of CA 15.3, CT and positron emission
tomography (PET)/CT in patients with breast cancer and suspected disease relapse after …

OBJECTIVE. Our aim was to evaluate the impact of FDG PET on defining the extent of
disease and on the treatment of patients with advanced breast cancer. MATERIALS AND …

Background We compared overall survival for metastatic breast cancer (MBC) patients
monitored with CE-CT, FDG-PET/CT or a combination of them in an observational setting …

BACKGROUND. Early diagnosis of recurrent breast cancer is crucial to selection of the most
appropriate therapy. The current study evaluated the role of FDG‐PET/CT in the assessment …

OBJECTIVE (S): Only few information exist about the diagnostic accuracy of PET/CT for
restaging patients with metastatic recurrence of breast carcinoma. Therefore, our study …

In this analysis, the role of metabolic imaging with fluorine 18 fluorodeoxyglucose (FDG) in
breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art …

Background The incremental value of 18 FDG PET/CT in patients with breast cancer (BC)
compared to conventional imaging (CI) in clinical practice is unclear. The aim of this study …

This study was conducted to determine the ability of 18F-FDG PET and conventional
imaging (CI) to predict the outcomes in breast cancer patients who have previously …

Abstract 18F-Fluoro-2-deoxy-d-glucose positron emission tomography (FDG PET) has been
evaluated in breast cancer for the characterisation of primary tumours, lymph node staging …